Table 2.
Estimated marginal means from mixed effect model for symptom and quality of life assessments
| Timepoint–mean (SE) | ||||||
|---|---|---|---|---|---|---|
| Variable | Baseline | Week 1 | Week 2 | Week 3 | Week 4 | |∆ Baseline–week 4 active vs sham| (95% CI) |
| SSI | ||||||
| Active | 2.0 (0.9) | 2.1 (0.9) | 0.9 (0.9) | 1.4 (0.9) | 0.5 (0.9) | |
| Sham | 3.3 (0.8) | 2.8 (0.8) | 3.0 (0.8) | 3.2 (0.8) | 2.3 (0.8) | 0.4 (−2.2 to 2.9) |
| BSI | ||||||
| Active | 9.0 (1.2) | 7.6 (1.2) | 6.6 (1.2) | 6.5 (1.3) | 5.8 (1.3) | |
| Sham | 8.9 (1.2) | 7.7 (1.2) | 8.6 (1.2) | 7.3 (1.2) | 7.0 (1.2) | 1.4 (−1.2 to 3.9) |
| SF-36 | ||||||
| Active | 100.4 (1.6) | NA | NA | NA | 101.6 (1.7) | |
| Sham | 99.5 (1.5) | NA | NA | NA | 99.8 (1.5) | 0.9 (−5.7 to 3.8) |
Fixed effects included in model were treatment allocation, time, and treatment × time interaction and participant identifiers were a random effect (random intercept)
SSI Scale for Suicidal Ideation, BSI Brief Symptom Inventory, SF-36 36-Item Short Form Survey